Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Therapy areas
Psychiatry
Psychiatry
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psychiatry
Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
Biospace News
-
December 19, 2019
Psychiatry
Minerva Neurosciences scraps antidepressant drug candidate MIN-117 after failed mid-stage trial
Psychiatry
Axsome’s experimental drug AXS-05 hits main goal of late-stage major depressive disorder study
Psychiatry
Acadia details positive results from late-stage study of pimavanserin for dementia-related psychosis
Psychiatry
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
Psychiatry
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
0
Psychiatry
Alkermes to Present New Data From Mental Health Portfolio at the...
Biospace News
-
May 22, 2019
0
Psychiatry
Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the...
Firstwordpharma News
-
May 16, 2019
0
Psychiatry
Once-Daily Trazodone as Effective as Venlafaxine XR for Major Depressive Disorder:...
Firstwordpharma News
-
April 10, 2019
0
Psychiatry
Achieve Life Sciences Announces Successful Completion of the Second and Final...
Biospace News
-
April 2, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Dupixent Wins Approval to Treat Chronic Rhinosinusitis with Nasal Polyposis
June 27, 2019
XTANDI (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3...
February 11, 2020
Gilead Plans NDA for Rheumatoid Arthritis Drug Filgotinib
July 2, 2019
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class...
April 11, 2019
Load more
HOT NEWS
Orphan-paediatric
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2...
Others
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
NDA
Sanofi Lines Up for Potential Approval of Cold Agglutinin Disease Treatment
Clinical
Intellipharmaceutics’ shares dive after FDA panel rejects opioid pain drug Aximris...
